Public Health England
The UK pneumococcal conjugate vaccine (PCV) immunisation programme has successfully achieved high levels of population (herd) protection for all age groups.
Currently, circulation of the 13 pneumococcal serotypes contained in the vaccine, and therefore, the risk of disease due to these serotypes, even in those at higher risk, is very low in the UK.
The PCV13 immunisation schedule has therefore been changed as follows:
infants born on or after 1 January 2020 should be offered a single dose of PCV13 alongside their routine DTaP/IPV/Hib/HepB and rotavirus immunisations at 12 weeks of age, followed by a PCV13 booster at one year of age (on or after their first birthday). This will be referred to as the 1+1 PCV13 schedule
infants born on or before 31 December 2019 will continue to receive two doses of PCV13 vaccine alongside their routine immunisations at 8 and 16 weeks of age, followed by a PCV13 booster at one year of age (on or after their first birthday). This will be referred to as the 2+1 PCV13 schedule
The one-year booster dose should be given regardless of the number of doses given under one year of age.